Nuance Pharma Acquires Sino Health To Further Strengthen Its Commercial Capabilities And Expand Pipelines
Jan 06, 2022•almost 4 years ago
Acquiring Company
Mainspring Energy
Acquired Company
Sino Health
Menlo ParkEnergy StorageSolarRenewable EnergyEnergyManufacturingOtherDescription
Nuance Pharma ("Nuance"or the "Company"), a specialty care focused biopharma with late late-stage clinical programs and existing commercial operations, today announced an agreement with Sino Health Pharmaceutical Limited ("Sino Health") , an affiliated company of Yinglian Pharmaceutical Holdings Group Limited, to fully acquire its 100-percent equity shares and its fully-owned subsidiaries Ying Lian Zhuhai and Ying Lian Germany.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed